{"id":"W4244728752","doi":"10.1093/neuonc/noaa215.238","title":"CTNI-72. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE GLIOBLASTOMA IN THE RECURRENT AND ADJUVANT SETTING","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Bevacizumab; Medicine; Internal medicine; Oncology; Adjuvant; Radiation therapy; Adjuvant therapy; Cancer; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008348484,0.001598275,0.001450986,0.0004086659,0.0003495824,0.0007860089,0.0007176214,0.0009440896,0.002575127],"category_scores_gemma":[0.000461317,0.0005345886,0.000882894,0.0003937302,0.0008114456,0.0005499166,0.0002495628,0.002651434,0.0007295662],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001057489,"about_ca_system_score_gemma":0.001706621,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002305949,"about_ca_topic_score_gemma":0.006953291,"domain_scores_codex":[0.9997639,0.00009487407,0.000009256885,0.00004569436,0.00002045454,0.00006568502],"domain_scores_gemma":[0.9996603,0.00002689917,0.00005140982,0.00002280936,0.00002061873,0.0002180192],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7818021,0.07170501,0.005016715,0.0004774183,0.0008015491,0.0002445524,0.000229628,0.002165585,0.06693126,0.00028676,0.003348672,0.06699084],"study_design_scores_gemma":[0.4015107,0.5801783,0.009010914,0.00002498944,0.0003966141,0.0002166745,0.00005875435,0.001050946,0.005341392,0.0001390932,0.002035645,0.00003602387],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954471,0.001079518,0.0002205627,0.0002272288,0.00008760091,0.001151183,0.0006079642,0.0000837175,0.001095155],"genre_scores_gemma":[0.9926036,0.001082377,0.0008139266,0.0004068568,0.0001040727,0.001310469,0.001456156,0.00002325714,0.002199262],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002575127,"threshold_uncertainty_score":0.008614659,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01619138088535579,"score_gpt":0.2998533169003955,"score_spread":0.2836619360150398,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}